Abbvie (ABBV) PT Lowered to $80 at Piper Jaffray
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $256.46 -1.44%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Piper Jaffray analyst Christopher Raymond lowered the price target on Abbvie (NYSE: ABBV) to $80.00 (from $90.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AbbVie's etentamig meets Phase 3 endpoints in multiple myeloma trial
- Mama’s Creations (MAMA) PT Lowered to $22 at DA Davidson Following Q2 Beat
- Phreesia Inc. (PHR) PT Lowered to $13 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
